KN057

· Suzhou Alphamab Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for KN057, covering 2024-12-24 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety of KN057 Prophylaxis in Patients With Haemophilia A or B [Phase 3]